Form 4: Pfizer Director Shantanu Narayen Acquires Phantom Stock Units as Part of Deferred Compensation

Pfizer director Shantanu Narayen acquired 1,884.659 phantom stock units as part of deferred compensation, which will be settled in cash or common stock upon retirement.

Summary

• Shantanu Narayen, a director at Pfizer Inc., has acquired 1,884.659 phantom stock units.
• These units are part of a deferred compensation plan for directors.
• The units represent the right to receive one share of common stock or cash equivalent per unit.
• The settlement of these units will occur after Mr. Narayen's retirement from the Board of Directors, at his election.
• The price of the underlying common stock at the time of the transaction was $26.53 per share.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is a neutral to slightly positive event. It indicates alignment of interests between the director and the company's long-term performance.

Positives

• The acquisition of phantom stock units aligns the director's interests with the long-term performance of the company.
• The deferred compensation plan is a common practice for retaining and incentivizing board members.

Future Outlook

The phantom stock units will be settled in cash or common stock at the director's election following his retirement from the Board of Directors.

Industry Context

The use of phantom stock units as part of director compensation is a common practice in publicly traded companies to align the interests of board members with those of shareholders.

Comparison to Industry Standards

• Deferred compensation plans, including phantom stock units, are a standard practice for compensating directors at large, publicly traded companies like Pfizer.
• Companies such as Johnson & Johnson (JNJ) and Merck (MRK) also utilize similar compensation structures for their board members.
• The value of the phantom stock units is tied to the company's stock performance, which is a common method to incentivize long-term value creation.

Stakeholder Impact

• The acquisition of phantom stock units aligns the director's interests with those of shareholders, as the value of the units is tied to the company's stock performance.
• The deferred compensation plan is a common practice for retaining and incentivizing board members, which is beneficial for the company's long-term stability.

Key Dates

Keywords

Pfizer, Director, Shantanu Narayen, Phantom Stock Units, Deferred Compensation, SEC Form 4, Beneficial Ownership